Sectors:
Locations:
Min Investment:
Max Investment:
Target Investment:
2018
2023
2022
2020
2021 - 2024
2021 - 2024
Acquired by Abbvie.
2022 - 2023
2022 - 2023
Represent a major shareholder to guide the company on a $15M Series A financing, which was successfully closed in April 2023.
2021 - 2022
2021 - 2022
Independent Board member focussed on strategic discussions around partnerships/investments. Guided the organization in its reabsorbtion back into the parent (CMPA)
2018 - 2022
2018 - 2022
2015 - 2018
2015 - 2018
2014 - 2015
2014 - 2015